Petco (WOOF) Reported Adjusted EBITDA Growth but a $6.8M Tariff Refund Helped the Quarter. Is the Turnaround Self-Funding?
Petco Health and Wellness (WOOF) reported Q2 2026 net sales of $1.49B, up 0.05%, with adjusted EBITDA of $122.2M, including a $6.8M tariff refund. Excluding the refund, EBITDA grew 1.3%. Gross margin increased 37 bps to 39.7%. The company reaffirmed full-year guidance and reduced debt to $1.48B.
How this was made
The 30-second read
Why it matters
The earnings release provides fresh data for valuation models and may trigger short‑term price movement.
Market read
Mid‑cap consumer discretionary earnings with guidance; relevant for traders targeting earnings‑driven moves.
What to watch
Pre‑payment of $75M debt reduces leverage but may strain free cash flow if operating cash slows.
Background
Petco Health and Wellness Company reported Q2 2026 results, highlighting modest sales growth, cash generation, and a tariff refund that inflated EBITDA.
Ticker impact
Q2 2026 earnings disclosed adjusted EBITDA $122.2M, net sales $1.49B and reaffirmed FY guidance.
Potential short‑term upside if market discounts the refund and focuses on cash flow improvement; downside risk if refund is seen as non‑recurring.
Numbers are fresh, sizable for a mid‑cap, and include guidance that can shift valuation.
Market effects
Pet care sector may see modest re‑rating as cash flow improves but growth remains limited.
U.S. consumer discretionary sentiment slightly affected.
Limited; impact confined to pet‑care and related retail stocks.
Counterpoint
The EBITDA boost is largely non‑recurring; investors should focus on underlying sales weakness.
Key entities
- companyPetco Health and Wellness Company, Inc.
Subject of the earnings report.
